SMAD3 and neoplasm: Because TGF-β signaling occurs during human hepatocellular carcinogenesis and involves a shift in TGF-β/Smad3 function [26], we speculated that the tumor-suppressive function of IL-37b might be implicated in TGF-β signaling.